SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001576885-24-000057
Filing Date
2024-04-22
Accepted
2024-04-22 16:33:07
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-22

Document Format Files

Seq Description Document Type Size
1 ARS acumenarsfilingprint-ready.pdf ARS 16811787
  Complete submission text file 0001576885-24-000057.txt   23156396
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40551 | Film No.: 24861597
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)